{"id":65175,"date":"2025-03-01T00:02:32","date_gmt":"2025-03-01T00:02:32","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/03\/01\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/"},"modified":"2025-03-01T00:02:32","modified_gmt":"2025-03-01T00:02:32","slug":"transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/","title":{"rendered":"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons"},"content":{"rendered":"<div>\n<p><strong>Company Announcement<\/strong><\/p>\n<p><strong>COPENHAGEN, Denmark; February 28, 2025 \u2013 <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D2sj2R5dwL_JySw2pmXxjJdzXxZOdPJO9_7FSCkfqHIOD9grQIbNAfLfJQ3gDXZ20JDjz3_YJSr7RSCg6EYvTg==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>Genmab A\/S<\/strong><\/a><strong> (Nasdaq: GMAB) &#8211; <\/strong><strong>In accordance with Article 19 of Regulation No. 596\/2014 on Market Abuse and Implementing Regulation 2016\/523, this document discloses the data of the transactions made in Genmab A\/S (Nasdaq: GMAB) by managerial employees and their closely associated persons.<\/strong><\/p>\n<p><strong>The company\u2019s managerial employees and their closely associated persons have given Genmab A\/S power of attorney on their behalf to publish trading in Genmab shares by the company\u2019s managerial employees and their closely associated persons.<\/strong><\/p>\n<p><strong>About Genmab<\/strong>\u00a0<br \/>Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody therapeutics. For more than 25 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab\u2019s vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO) antibody medicines<sup>\u00ae<\/sup>.\u202f<\/p>\n<p>Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with international presence across North America, Europe and Asia Pacific. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D2sj2R5dwL_JySw2pmXxjPnhdUbbOQWKbhIRNykKdpPbIQk4oHYlyefozlkIM91t5L6e77WkPDcMX3ShK6NQfJvIF04qby4_77ioVGn5SI0obMgjY5iPqxKel6LjVJzTFQfNn3WHCwloasPDRivUpzEphzFygaGRxNlQRoKJwOzyusxXn-cJGGkL2-TskCCGGhXYllqZb2BnMF68Vf8SZKbm1z4Zifzu6OzNPLQWlrs=\" rel=\"nofollow\" target=\"_blank\" title=\"Genmab.com\">Genmab.com<\/a>\u202fand follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=93mME37KAnRemxLj6NyoLwtfOqjOMLL3MjjljdYGe-GAXaU8k7B_3-ICj-dTripKD5UTIR7SYmeJGNiD3DnLFNwkHhv6V-1-HmSCpbWzlxU=\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Uv-N8zophMh6PjSBsjZsHW1w7qfIofcZr7hFBtPlCM4xy_YpvAnAJVXn3E91tHrFXQp_uQ7yuz_IFV1FmwoUAg==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a>.<\/p>\n<p><strong>Contact:<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Marisol Peron, Senior Vice President, Global Communications &amp; Corporate Affairs<br \/>T: +1 609 524 0065; E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q9Rysi3P2O5xiFgaENiYalY87DFlbIaCf0lPap701wInymedi0cSbGTRHudOJvG9OTxx0kjqYZQPpP3VWp5sxw==\" rel=\"nofollow\" target=\"_blank\" title=\"mmp@genmab.com\">mmp@genmab.com<\/a><\/p>\n<p>Andrew Carlsen, Vice President, Head of Investor Relations<br \/>T: +45 3377 9558; E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A0EGMmFbQj9gXO36hjbO8l7KfP85k7GCHOoTKZhdJAph92tRYObJ9X6B9of-SxlDyIim7uUbSiuh2cPOoqxoIw==\" rel=\"nofollow\" target=\"_blank\" title=\"acn@genmab.com\">acn@genmab.com<\/a> <\/p>\n<p><em>The Company Announcement contains forward looking statements. The words \u201cbelieve,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cintend\u201d and \u201cplan\u201d and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with preclinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab\u2019s most recent financial reports, which are available on <\/em><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RtyAF1vMRAlVpRiFDOZLzqdAQHooNlEe3--j3t5b4FqCjl0ExrGsiAWSoOT76g3g_1bzcEeFQWnUxHSzLRmYEw==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><em>www.genmab.com<\/em><\/a> <em>and the risk factors included in Genmab\u2019s most recent Annual Report on Form 20-F and other filings <\/em><em>with the U.S. Securities and Exchange Commission (SEC), which are available at <\/em><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RtyAF1vMRAlVpRiFDOZLzuD69OAssjI9ZcM1ALui2T9RQRYhgYHvRSZTrykKhTd8_pjOJYYG9yLFtw2io8RE0S3gNYGHGitxLPuPh_53vC4=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><em>www.sec.gov<\/em><\/a><em>. Genmab does not undertake any obligation to update or revise forward looking statements in the Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law. <\/em><\/p>\n<p><em>Genmab A\/S and\/or its subsidiaries own the following trademarks: Genmab<\/em><sup><em>\u00ae<\/em><\/sup><em>; the Y-shaped Genmab logo<\/em><sup><em>\u00ae<\/em><\/sup><em>; Genmab in combination with the Y-shaped Genmab logo<\/em><sup><em>\u00ae<\/em><\/sup><em>; HuMax<\/em><sup><em>\u00ae<\/em><\/sup><em>; DuoBody<\/em><sup><em>\u00ae<\/em><\/sup><em>; HexaBody<\/em><sup><em>\u00ae<\/em><\/sup><em>; DuoHexaBody<\/em><sup><em>\u00ae<\/em><\/sup><em>, HexElect<\/em><sup><em>\u00ae <\/em><\/sup><em>and KYSO<\/em><sup>\u00ae<\/sup><em>.<\/em><\/p>\n<p>CVR no. 2102 3884<br \/>LEI Code 529900MTJPDPE4MHJ122<\/p>\n<p>Genmab A\/S<br \/>Carl Jacobsens Vej 30<br \/>2500\u00a0Valby<br \/> Denmark<\/p>\n<p id=\"gnw_attachments_section-header\">\n    <strong>Attachment<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=dqGr-U7NrxoX39PWaJ22DUUomSnzpfE7-VBLGllsYdQD__EwKYhk2desubwEyKC8zcjiqQw6sbRIFy4PFfqc9GUwVjp6cVxewoIA0TqLK6mRD8Pqgk_yFj5xpoBNqI0f7RbW1azX2NARCiH7-d3tCJAQIRIXO5IfFZPZbNBg8AsbKP3cuLmVLeJFWM6nMPY1l0Ic7AdXktoNRh0JnlPzUg==\" title=\"280225_CA07_Managerial Employee Transactions\" rel=\"nofollow\">280225_CA07_Managerial Employee Transactions<\/a>\n      <\/li>\n<\/ul>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/YmU5YWQyNmMtNmUzZi00YjU5LWJlMmQtNzAzMjQxMjZlYmFjLTEwMTMyNDE=\/tiny\/Genmab-A-S.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Company Announcement COPENHAGEN, Denmark; February 28, 2025 \u2013 Genmab A\/S (Nasdaq: GMAB) &#8211; In accordance with Article 19 of Regulation No. 596\/2014 on Market Abuse and Implementing Regulation 2016\/523, this document discloses the data of the transactions made in Genmab A\/S (Nasdaq: GMAB) by managerial employees and their closely associated persons. The company\u2019s managerial employees [&#8230;]\n","protected":false},"author":1,"featured_media":65176,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-65175","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons\" \/>\n<meta property=\"og:description\" content=\"Company Announcement COPENHAGEN, Denmark; February 28, 2025 \u2013 Genmab A\/S (Nasdaq: GMAB) &#8211; In accordance with Article 19 of Regulation No. 596\/\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-01T00:02:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/03\/Genmab-A-S.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons\",\"datePublished\":\"2025-03-01T00:02:32+00:00\",\"dateModified\":\"2025-03-01T00:02:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/\"},\"wordCount\":563,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/\",\"name\":\"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-03-01T00:02:32+00:00\",\"dateModified\":\"2025-03-01T00:02:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/","og_locale":"en_US","og_type":"article","og_title":"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons","og_description":"Company Announcement COPENHAGEN, Denmark; February 28, 2025 \u2013 Genmab A\/S (Nasdaq: GMAB) &#8211; In accordance with Article 19 of Regulation No. 596\/","og_url":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-03-01T00:02:32+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/03\/Genmab-A-S.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons","datePublished":"2025-03-01T00:02:32+00:00","dateModified":"2025-03-01T00:02:32+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/"},"wordCount":563,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/","url":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/","name":"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-03-01T00:02:32+00:00","dateModified":"2025-03-01T00:02:32+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Transactions with shares and linked securities in Genmab A\/S made by managerial employees and their closely associated persons"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/65175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=65175"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/65175\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/65176"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=65175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=65175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=65175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}